Información del producto
Nombre:SBI-477
Marca:Biosynth
Descripción:SBI-477 is a novel drug candidate that has been shown to have significant efficacy in the treatment of various muscle diseases, including Duchenne muscular dystrophy. It is a fatty acid ester and interacts with the cellular membrane, preventing the uptake of nutrients. SBI-477 has also been shown to have anticancer properties due to its ability to inhibit cancer cell proliferation by blocking insulin receptor signaling. SBI-477 has been shown to block interactions between proteins by targeting an interactome. Additionally, this drug has been shown to be effective in treating acute lymphoblastic leukemia (ALL) in children because it blocks the growth of leukemia cells by interfering with their ability to proliferate and synthesize DNA.
Aviso:Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Propiedades químicas
Peso molecular:483.5 g/mol
Fórmula:C24H25N3O6S
Pureza:Min. 95%
Consulta técnica sobre: SBI-477
Use el carrito para solicitar presupuestos o pedidos
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.